Qualigen Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Changes in Control of Registrant, Other Events, Financial Statements and Exhibits
Qualigen Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Changes in Control of Registrant, Other Events, Financial Statements and Exhibits | Quantisnow